J B Chemicals &

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE572A01036
  • NSEID: JBCHEPHARM
  • BSEID: 506943
INR
1,846.00
-10.3 (-0.55%)
BSENSE

Jan 29

BSE+NSE Vol: 1.3 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationNine Monthly Results
Results Snapshot
Figures in Cr
Consolidate Nine Monthly Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
3,243.56
2,968.51
2,622.45
2,386.96
1,799.66
1,514.07
1,331.16
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
3,243.56
2,968.51
2,622.45
2,386.96
1,799.66
1,514.07
1,331.16
Raw Material Cost
678.73
631.06
639.10
594.10
441.75
407.22
331.72
Purchase of Finished goods
375.09
360.99
236.82
331.87
197.24
160.24
146.91
(Increase) / Decrease In Stocks
-31.80
2.86
5.85
-32.63
-8.88
-60.48
5.18
Employee Cost
573.97
510.79
448.71
407.82
323.01
254.44
237.40
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
-0.01
-0.01
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
741.28
657.41
593.20
553.69
428.01
316.15
324.12
Total Expenditure (Excl Depreciation)
2,337.27
2,163.11
1,923.68
1,854.85
1,381.13
1,077.56
1,045.32
Operating Profit (PBDIT) excl Other Income
906.29
805.40
698.77
532.11
418.53
436.51
285.84
Other Income
48.17
23.84
20.64
5.36
37.15
87.03
47.50
Operating Profit (PBDIT)
954.46
829.24
719.41
537.47
455.68
523.54
333.34
Interest
4.34
10.28
34.92
22.09
3.50
6.55
2.53
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
950.12
818.96
684.49
515.38
452.18
516.99
330.81
Depreciation
132.49
124.60
97.58
82.61
50.55
52.13
48.93
Profit Before Tax
817.63
694.36
586.91
432.77
401.63
464.86
281.86
Tax
209.54
180.47
160.44
110.39
100.56
117.15
59.55
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
608.09
513.89
426.47
322.38
301.07
347.71
222.32
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
608.09
513.89
426.47
322.38
301.07
347.71
222.32
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
-0.17
-0.09
0.00
-0.07
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
608.09
513.89
426.47
322.21
300.52
347.35
221.91
Equity Capital
15.67
15.55
15.50
15.46
15.46
15.46
16.05
Face Value
1.0
1.0
1.0
2.0
2.0
2.0
2.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Diluted Earnings per share
12.45
10.24
8.46
13.57
10.85
19.94
8.26
Operating Profit Margin (Excl OI)
27.94%
27.13%
26.65%
22.29%
23.26%
28.83%
21.47%
Gross Profit Margin
29.29%
27.59%
26.1%
21.59%
25.13%
34.15%
24.85%
PAT Margin
18.75%
17.31%
16.26%
13.51%
16.73%
22.97%
16.7%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Nine Monthly Analysis Highlights
stock-summary

Net Sales

YoY Growth in nine months ended Dec 2025 is 9.27% vs 13.20% in Dec 2024

stock-summary

Consolidate Net Profit

YoY Growth in nine months ended Dec 2025 is 18.33% vs 20.50% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in nine months ended Dec 2025 is 12.53% vs 15.26% in Dec 2024

stock-summary

Interest

YoY Growth in nine months ended Dec 2025 is -57.78% vs -70.56% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in nine months ended Dec 2025 has improved from Dec 2024

Compare Nine Monthly Results Of J B Chemicals & With
Markets Mojo
Figures in Cr
Consolidate Nine Monthly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
3,243.56
0
3,243.56
Other Operating Income
0.00
0.00
0.00
Total Operating income
3,243.56
0
3,243.56
Raw Material Cost
678.73
0
678.73
Purchase of Finished goods
375.09
0
375.09
(Increase) / Decrease In Stocks
-31.80
0
-31.80
Employee Cost
573.97
0
573.97
Power Cost
0.00
0
0.00
Manufacturing Expenses
0.00
0
0.00
Selling and Distribution Expenses
0.00
0
0.00
Other Expenses
741.28
0.00
741.28
Total Expenditure (Excl Depreciation)
2,337.27
0
2,337.27
Operating Profit (PBDIT) excl Other Income
906.29
0.00
906.29
Other Income
48.17
0
48.17
Operating Profit (PBDIT)
954.46
0
954.46
Interest
4.34
0
4.34
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
950.12
0
950.12
Depreciation
132.49
0
132.49
Profit Before Tax
817.63
0
817.63
Tax
209.54
0
209.54
Provisions and contingencies
0.00
0
0.00
Profit After Tax
608.09
0
608.09
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0.00
0
0.00
Other Adjustments
0.00
0
0.00
Net Profit
608.09
0
608.09
Share in Profit of Associates
0.00
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
608.09
0
608.09
Equity Capital
15.67
0
15.67
Face Value
1.00
0
0.00
Reserves
0.00
0
0.00
Gross Profit Margin
29.29%
0.00%
0.00
29.29%
PAT Margin
18.75%
0.00%
0.00
18.75%
Public Share Holdings (%)
0.00%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0%
0.00
0.00%
Nine Monthly - Net Sales
Net Sales 3,243.56 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is 9.27% vs 13.20% in Dec 2024

Nine Monthly - Consolidate Net Profit
Consolidate Net Profit 608.09 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is 18.33% vs 20.50% in Dec 2024

Nine Monthly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 906.29 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is 12.53% vs 15.26% in Dec 2024

Nine Monthly - Interest
Interest 4.34 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is -57.78% vs -70.56% in Dec 2024

Nine Monthly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 27.94%
in Dec 2025

Figures in %
stock-summary

YoY Growth in nine months ended Dec 2025 has improved from Dec 2024